Smad3 null mice display more rapid wound closure and reduced scar formation after a stab wound to the cerebral cortex
暂无分享,去创建一个
Yu Wang | Helina Moges | A. Symes | Yu Wang | H. Moges | Yasmin Bharucha | Yasmin Bharucha | Aviva Symes | Helina Moges
[1] L M Wakefield,et al. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[2] J. Massagué,et al. Smad transcription factors. , 2005, Genes & development.
[3] P. Hoodless,et al. Smad2 and Smad3 positively and negatively regulate TGF beta-dependent transcription through the forkhead DNA-binding protein FAST2. , 1998, Molecular cell.
[4] G. Piras,et al. A role for TGF-beta in oligodendrocyte differentiation , 1993, The Journal of cell biology.
[5] Jack M Parent,et al. Rat forebrain neurogenesis and striatal neuron replacement after focal stroke , 2002, Annals of neurology.
[6] Stacey P. Memberg,et al. Regeneration of adult axons in white matter tracts of the central nervous system , 1997, Nature.
[7] M. Sporn,et al. Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes , 1989, The Journal of cell biology.
[8] J. Massagué,et al. Transcriptional control by the TGF‐β/Smad signaling system , 2000 .
[9] J. Massagué. Integration of Smad and MAPK pathways: a link and a linker revisited. , 2003, Genes & development.
[10] L. Mucke,et al. Astroglial overproduction of TGF-β1 enhances inflammatory central nervous system disease in transgenic mice , 1997, Journal of Neuroimmunology.
[11] W. Chambers,et al. Inhibition of formation of a glial barrier as a means of permitting a peripheral nerve to grow into the brain , 1952, The Journal of comparative neurology.
[12] James W. Fawcett,et al. Chondroitinase ABC promotes functional recovery after spinal cord injury , 2002, Nature.
[13] M. Sporn,et al. Enhanced expression of transforming growth factor β1 in the rat brain after a localized cerebral injury , 1992, Brain Research.
[14] C. Finch,et al. Glial Fibrillary Acidic Protein Transcription Responses to Transforming Growth Factor‐β1 and Interleukin‐1β Are Mediated by a Nuclear Factor‐1‐Like Site in the Near‐Upstream Promoter , 1999, Journal of neurochemistry.
[15] Kohei Miyazono,et al. TGF-β signalling from cell membrane to nucleus through SMAD proteins , 1997, Nature.
[16] K. Miyazono,et al. Identification of receptors and Smad proteins involved in activin signalling in a human epidermal keratinocyte cell line , 1998, Genes to cells : devoted to molecular & cellular mechanisms.
[17] P. Hoodless,et al. Smad2 Signaling in Extraembryonic Tissues Determines Anterior-Posterior Polarity of the Early Mouse Embryo , 1998, Cell.
[18] R. Kucherlapati,et al. Postgastrulation Smad2-deficient embryos show defects in embryo turning and anterior morphogenesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[19] Jeffrey L. Wrana,et al. TGFβ signals through a heteromeric protein kinase receptor complex , 1992, Cell.
[20] M. Sporn,et al. Transforming Growth Factor‐&bgr;1 Reduces Infarct Size After Experimental Cerebral Ischemia in a Rabbit Model , 1993, Stroke.
[21] James B. Graham,et al. Regeneration of Axons after Nerve Transection Repair Is Enhanced by Degradation of Chondroitin Sulfate Proteoglycan , 2002, Experimental Neurology.
[22] B. Trapp,et al. NG2+ glial cells: a novel glial cell population in the adult brain. , 1999, Journal of neuropathology and experimental neurology.
[23] J. Fawcett,et al. Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC , 2001, Nature Neuroscience.
[24] R. Derynck,et al. SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS , 2005 .
[25] J. Fawcett,et al. Reduction in CNS scar formation without concomitant increase in axon regeneration following treatment of adult rat brain with a combination of antibodies to TGFβ1 and β2 , 2001, The European journal of neuroscience.
[26] M. Pierre,et al. Effects of transforming growth factor‐β1 on the extracellular matrix and cytoskeleton of cultured astrocytes , 1993 .
[27] A. Logan,et al. Expression of TGFβ2 but Not TGFβ1 Correlates with the Deposition of Scar Tissue in the Lesioned Spinal Cord , 2002, Molecular and Cellular Neuroscience.
[28] H. Hartung,et al. Microglia and macrophages are major sources of locally produced transforming growth factor‐β1 after transient middle cerebral artery occlusion in rats , 1998, Glia.
[29] R. Kucherlapati,et al. Functional Characterization of Transforming Growth Factor β Signaling in Smad2- and Smad3-deficient Fibroblasts* , 2001, The Journal of Biological Chemistry.
[30] E. Li,et al. Smad2 role in mesoderm formation, left–right patterning and craniofacial development , 1998, Nature.
[31] R. Akhurst,et al. Transforming growth factor βS: Biochemistry and biological activities in vitro and in vivo , 1996 .
[32] I. Wickelgren. Animal Studies Raise Hopes for Spinal Cord Repair , 2002, Science.
[33] V. Gallo,et al. Postnatal NG2 proteoglycan–expressing progenitor cells are intrinsically multipotent and generate functional neurons , 2003, The Journal of cell biology.
[34] Guo-Yuan Yang,et al. Reduction of Inflammatory Response in the Mouse Brain With Adenoviral-Mediated Transforming Growth Factor-&bgr;1 Expression , 2001, Stroke.
[35] Ngan B. Doan,et al. Reactive Astrocytes Protect Tissue and Preserve Function after Spinal Cord Injury , 2004, The Journal of Neuroscience.
[36] M. Berry,et al. Inhibition of glial scarring in the injured rat brain by a recombinant human monoclonal antibody to transforming growth factor‐β2 , 1999, The European journal of neuroscience.
[37] D. Kögel,et al. TGF-β1 activates two distinct type I receptors in neurons , 2005, The Journal of Cell Biology.
[38] J. Weiss,et al. Astrocyte expression of monocyte chemoattractant protein-1 is differentially regulated by transforming growth factor beta , 1998, Journal of Neuroimmunology.
[39] J. Schwab,et al. Differential cellular accumulation of connective tissue growth factor defines a subset of reactive astrocytes, invading fibroblasts, and endothelial cells following central nervous system injury in rats and humans. , 2001, Journal of neurotrauma.
[40] R. Berman,et al. Early loss of astrocytes after experimental traumatic brain injury , 2003, Glia.
[41] M. Sporn,et al. Effects of Transforming Growth Factor β1, on Scar Production in the Injured Central Nervous System of the Rat , 1994 .
[42] M. Sporn,et al. Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells , 1986, The Journal of cell biology.
[43] J. Silver,et al. Injury-Induced Proteoglycans Inhibit the Potential for Laminin-Mediated Axon Growth on Astrocytic Scars , 1995, Experimental Neurology.
[44] C. Culmsee,et al. The expression of transforming growth factor-beta1 (TGF-β1) in hippocampal neurons: a temporary upregulated protein level after transient forebrain ischemia in the rat , 2000, Brain Research.
[45] E. Schönherr,et al. Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. , 1991, The Journal of biological chemistry.
[46] P. Dijke,et al. New insights into TGF-β–Smad signalling , 2004 .
[47] E. Masliah,et al. Loss of TGF-β1 Leads to Increased Neuronal Cell Death and Microgliosis in Mouse Brain , 2003, Neuron.
[48] K. Khalili,et al. Regulation of MCP-1 gene transcription by Smads and HIV-1 Tat in human glial cells. , 2003, Virology.
[49] A. Nishiyama,et al. Transient expression of the NG2 proteoglycan by a subpopulation of activated macrophages in an excitotoxic hippocampal lesion , 2001, Glia.
[50] W. Vale,et al. Roles of pathway-specific and inhibitory Smads in activin receptor signaling. , 1999, Molecular endocrinology.
[51] J. Fawcett,et al. Chondroitin sulphate proteoglycans in the CNS injury response. , 2002, Progress in brain research.
[52] V. M. Neto,et al. Glial fibrillary acidic protein gene promoter is differently modulated by transforming growth factor‐beta 1 in astrocytes from distinct brain regions , 2004, The European journal of neuroscience.
[53] S. Gordon,et al. Polymorphic expression of a neutrophil differentiation antigen revealed by monoclonal antibody 7/4 , 2004, Immunogenetics.
[54] P. Gluckman,et al. Neuronal rescue with transforming growth factor-beta 1 after hypoxic-ischaemic brain injury. , 1994, Neuroreport.
[55] K. Flanders,et al. Smad3 as a mediator of the fibrotic response , 2004, International journal of experimental pathology.
[56] M. Sporn. Growth factors and cytokines in health and disease , 1997 .
[57] Clive N Svendsen,et al. Leukocyte Infiltration, Neuronal Degeneration, and Neurite Outgrowth after Ablation of Scar-Forming, Reactive Astrocytes in Adult Transgenic Mice , 1999, Neuron.
[58] T. Morgan,et al. Expression of vimentin increases in the hippocampus and cerebral cortex after entorhinal cortex lesioning and in response to transforming growth factor β 1 , 1995, Journal of Neuroimmunology.
[59] R. Brown,et al. The effects of treatment with antibodies to transforming growth factor β1 and β2 following spinal cord damage in the adult rat , 2004, Neuroscience.
[60] C. Abrass,et al. bcn-1 Element-dependent Activation of the Laminin γ1 Chain Gene by the Cooperative Action of Transcription Factor E3 (TFE3) and Smad Proteins* , 2002, The Journal of Biological Chemistry.
[61] J. Massagué,et al. Identification of human activin and TGFβ type I receptors that form heteromeric kinase complexes with type II receptors , 1993, Cell.
[62] Anita B. Roberts,et al. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response , 1999, Nature Cell Biology.
[63] N. Thompson,et al. Differential neuronal and astrocytic expression of transforming growth factor beta isoforms in rat hippocampus following transient forebrain ischemia. , 1996, Brain research. Molecular brain research.
[64] Mark H. Tuszynski,et al. NG2 Is a Major Chondroitin Sulfate Proteoglycan Produced after Spinal Cord Injury and Is Expressed by Macrophages and Oligodendrocyte Progenitors , 2002, The Journal of Neuroscience.
[65] G. Alonso,et al. NG2 proteoglycan‐expressing cells of the adult rat brain: Possible involvement in the formation of glial scar astrocytes following stab wound , 2005, Glia.
[66] J. Massagué,et al. Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.
[67] J. Levine,et al. NG2: a component of the glial scar that inhibits axon growth , 2005, Journal of anatomy.
[68] George M. Smith,et al. Growth factor and cytokine regulation of chondroitin sulfate proteoglycans by astrocytes , 2005, Glia.
[69] J. Silver,et al. Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[70] M. Berry,et al. Decorin Attenuates Gliotic Scar Formation in the Rat Cerebral Hemisphere , 1999, Experimental Neurology.
[71] Ying E. Zhang,et al. Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.
[72] Jerry Silver,et al. Regeneration beyond the glial scar , 2004, Nature Reviews Neuroscience.
[73] S. Davies,et al. Decorin suppresses neurocan, brevican, phosphacan and NG2 expression and promotes axon growth across adult rat spinal cord injuries , 2004, The European journal of neuroscience.
[74] R. Derynck,et al. Transcriptional Activators of TGF-β Responses: Smads , 1998, Cell.
[75] V. Perry,et al. Immunohistochemical localization of a macrophage-specific antigen in developing mouse retina: phagocytosis of dying neurons and differentiation of microglial cells to form a regular array in the plexiform layers , 1983, The Journal of cell biology.
[76] X. F. Wang,et al. Targeted Disruption of Smad3 Reveals an Essential Role in Transforming Growth Factor β-Mediated Signal Transduction , 1999, Molecular and Cellular Biology.
[77] L. Mucke,et al. Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-beta 1. , 1995, The American journal of pathology.
[78] P. Henrich-Noack,et al. TGF-beta 1 protects hippocampal neurons against degeneration caused by transient global ischemia. Dose-response relationship and potential neuroprotective mechanisms. , 1996, Stroke.
[79] L. Acarín,et al. Neuronal, astroglial and microglial cytokine expression after an excitotoxic lesion in the immature rat brain , 2000, The European journal of neuroscience.
[80] M. Tuszynski,et al. The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury , 2003, Experimental Neurology.
[81] M. Pierre,et al. Rapid TGFβ1 effects on actin cytoskeleton of astrocytes: Comparison with other factors and implications for cell motility , 1995, Glia.
[82] J. Fawcett,et al. Relationship between sprouting axons, proteoglycans and glial cells following unilateral nigrostriatal axotomy in the adult rat , 2002, Neuroscience.
[83] J. Fawcett,et al. The glial scar and central nervous system repair , 1999, Brain Research Bulletin.
[84] S. K. Malhotra,et al. Reactive astrocytes: cellular and molecular cues to biological function , 1997, Trends in Neurosciences.
[85] J. Massagué,et al. Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways , 1996, Nature.
[86] A. Roberts,et al. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF‐β , 1999, The EMBO journal.
[87] U. Lendahl,et al. Abnormal Reaction to Central Nervous System Injury in Mice Lacking Glial Fibrillary Acidic Protein and Vimentin , 1999, The Journal of cell biology.